Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 143.26
0.944 %
$ 14.5 B
Market Cap
38.2
P/E
NBIX - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities NBIX - Neurocrine Biosciences, Inc.
-467 M
LAST VALUE
-89.41%
2 YEAR CAGR
-13.97%
5 YEAR CAGR
-56.56%
10 YEAR CAGR